Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
One in every four US households has someone living with migraine. More than a severe headache, migraine is a complex neurological disorder impacting 39 million Americans with more than $36B lost each year in medical expenses and lost productivity. Despite its...
There are mixed prostate-specific antigen (PSA) screening recommendations for men of varying ages. The objective of this study was to describe variation in first-time PSA values across demographic and SDOH factors. In a study of nearly 4 million men with PSA lab...
This post is the first of six deep dives I plan to do into the significant technology challenges we have solved at Truveta using the power of AI to enable healthcare research using real-world data. Today I would like to talk about our approach to answering: How to...
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) increased throughout the first quarter of 2024 (+20.9% increase in March 2024 compared to December 2023). First-time prescribing rates (first-time GLP-1 RA prescriptions per total...
Norovirus and rotavirus are significant contributors to gastrointestinal infections worldwide, creating risk for patient populations and strain on the healthcare system. Truveta Research evaluated trends in norovirus- and rotavirus-associated hospitalizations overall...
You probably know someone who will be diagnosed with prostate cancer in their lifetime. 1 in 8 men will develop prostate cancer, with a higher risk in Black and African American men and an overall increased risk after the age of 65. While most cases are not fatal,...
Truveta Research and collaborators Anupam B. Jena, MD, PhD and Christopher Worsham, MD, MPH received the ISPOR 2024 Best General Poster Research Presentation Award for their poster presentation, HSD72: Baseline A1C and BMI Trends for People with Type 2 Diabetes...
Recently, researchers presented new insights from a continued analysis of the REAL-PE study at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. To address a lack of sufficient clinical guidance on how to best treat pulmonary embolism...
Today Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors ensures Truveta is operating in pursuit of its mission, providing strategic, scientific, and operational direction. With...
